Eurofins Scientific SE

ERF

FR0014000MR3

Healthcare Facilities & Services

Market Closed - Euronext Paris Other stock markets 16:36:01 15/07/2024 BST			5-day change	1st Jan Change
47.68 ^EUR	-2.73%		+1.99%	-19.16%

07-15	Eurofins: dispute with SGS over termination of contract	CF
07-11	Eurofins: further clarifications for the market	CF

Eurofins Scientific SE acquired LABORMAR.

July 07, 2024

Eurofins Scientific SE (ENXTPA:ERF) acquired LABORMAR on July 8, 2024.

Eurofins Scientific SE (ENXTPA:ERF) completed the acquisition of LABORMAR on July 8, 2024.

Latest news about Eurofins Scientific SE

Eurofins: dispute with SGS over termination of contract	07-15	CF
Eurofins: further clarifications for the market	07-11	CF
Eurofins to share more details on real estate programme in response to Muddy Waters	07-11	RE
Eurofins says it is ready to detail its real estate program in response to Muddy Waters	07-11	RE
Eurofins Scientific SE acquired LABORMAR.	07-07	CI
North American Morning Briefing : Stock Futures Tick Higher Before Payrolls Data	07-05	DJ
Eurofins: Muddy Waters' accusations again rejected	07-05	CF
Eurofins Scientific Issues Second Rebuttal of Muddy Waters Allegations	07-03	MT
CAC40: up sharply despite gloomy PMIs	07-03	CF
Europe rebounds ahead of PMIs, supported by Powell	07-03	RE
Eurofins once again refutes Muddy Waters' allegations	07-03	RE
Eurofins: second denial of MW accusations	07-03	CF
New semester, new state of mind	07-01
Eurofins Scientific Unit to Sell Nightingale's Blood Analysis test in the US	06-28	MT
Market Update-Europe closes lower in a session marked by a wait-and-see attitude	06-25	RE
EUROFINS : Oddo BHF confirms its recommendation on the stock	06-25	CF
European shares fall as Airbus hammers aerospace shares, tech slips	06-25	RE
Eurofins: Muddy Waters' accusations rejected	06-25	CF
Europe in the red with tech and political risk	06-25	RE
Eurofins denies allegations of embezzlement by Muddy Waters	06-25	RE
EUROFINS SCIENTIFIC : Eurofins’ share price tanks after short seller report	06-24
European shares start the week higher on autos, banks	06-24	RE
Eurofins Scientific Faces Alleged 'Material Overstatements' from Muddy Waters Research	06-24	MT
MORNING BID AMERICAS-Transatlantic split reopens as half-year nears	06-24	RE
Lab testing firm Eurofins slumps after Muddy Waters report, short position	06-24	RE

Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).

Sector

Healthcare Facilities & Services

Calendar

24/07/2024 - Q2 2024 Earnings Release

Related indices

CAC 40 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

EUROFINS SCIENTIFIC : Eurofins’ share price tanks after short seller report

June 24, 2024 at 05:46 pm

More Strategies

Ratings for Eurofins Scientific SE

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

47.68 EUR

Average target price

59.69 EUR

Spread / Average Target

+25.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
EUROFINS SCIENTIFIC SE	-19.16%	10.31B
HCA HEALTHCARE, INC.	+17.11%	84.94B
CVS HEALTH CORPORATION	-25.70%	74.07B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	26.18B
FRESENIUS SE & CO. KGAA	+2.67%	18.03B
LABCORP HOLDINGS INC.	-8.71%	17.38B
QUEST DIAGNOSTICS INCORPORATED	+4.87%	16.01B
NATERA, INC.	+79.85%	13.7B
TENET HEALTHCARE CORPORATION	+73.90%	13.13B
PURE HEALTH HOLDING	-26.14%	12.74B

Other Healthcare Facilities & Services